BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

275 related articles for article (PubMed ID: 38254043)

  • 21. Antidiabetic and Immunoregulatory Activities of Extract of
    Lin CH; Kuo YH; Shih CC
    Int J Mol Sci; 2023 Jun; 24(12):. PubMed ID: 37373070
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Antibody combinations for optimized staining of macrophages in human lung tumours.
    Frafjord A; Skarshaug R; Hammarström C; Stankovic B; Dorg LT; Aamodt H; Woldbaek PR; Helland Å; Brustugun OT; Øynebråten I; Corthay A
    Scand J Immunol; 2020 Jul; 92(1):e12889. PubMed ID: 32299134
    [TBL] [Abstract][Full Text] [Related]  

  • 23. HHLA2 deficiency inhibits non-small cell lung cancer progression and THP-1 macrophage M2 polarization.
    Sun W; Li S; Tang G; Sun S; Luo Y; Bai R; Han L; Jiang X; Gao Y; Huang Z; Zhang J; Gong Y; Xie C
    Cancer Med; 2021 Aug; 10(15):5256-5269. PubMed ID: 34152094
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Human CD4+ T cells present within the microenvironment of human lung tumors are mobilized by the local and sustained release of IL-12 to kill tumors in situ by indirect effects of IFN-gamma.
    Hess SD; Egilmez NK; Bailey N; Anderson TM; Mathiowitz E; Bernstein SH; Bankert RB
    J Immunol; 2003 Jan; 170(1):400-12. PubMed ID: 12496425
    [TBL] [Abstract][Full Text] [Related]  

  • 25. LncRNA-HOXC-AS2 regulates tumor-associated macrophage polarization through the STAT1/SOCS1 and STAT1/CIITA pathways to promote the progression of non-small cell lung cancer.
    Yin C; Li J; Li S; Yang X; Lu Y; Wang C; Liu B
    Cell Signal; 2024 Mar; 115():111031. PubMed ID: 38168631
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Targeting MARCO and IL37R on Immunosuppressive Macrophages in Lung Cancer Blocks Regulatory T Cells and Supports Cytotoxic Lymphocyte Function.
    La Fleur L; Botling J; He F; Pelicano C; Zhou C; He C; Palano G; Mezheyeuski A; Micke P; Ravetch JV; Karlsson MCI; Sarhan D
    Cancer Res; 2021 Feb; 81(4):956-967. PubMed ID: 33293426
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Tumoral NOX4 recruits M2 tumor-associated macrophages via ROS/PI3K signaling-dependent various cytokine production to promote NSCLC growth.
    Zhang J; Li H; Wu Q; Chen Y; Deng Y; Yang Z; Zhang L; Liu B
    Redox Biol; 2019 Apr; 22():101116. PubMed ID: 30769285
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Human CD4+ effector memory T cells persisting in the microenvironment of lung cancer xenografts are activated by local delivery of IL-12 to proliferate, produce IFN-gamma, and eradicate tumor cells.
    Broderick L; Yokota SJ; Reineke J; Mathiowitz E; Stewart CC; Barcos M; Kelleher RJ; Bankert RB
    J Immunol; 2005 Jan; 174(2):898-906. PubMed ID: 15634912
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Demethylzeylasteral inhibits proliferation, migration and invasion and promotes apoptosis of non-small cell lung cancer cells by inhibiting the AKT/CREB signaling pathway].
    Han Q; Ye M; Jin Q
    Nan Fang Yi Ke Da Xue Xue Bao; 2024 Feb; 44(2):280-288. PubMed ID: 38501413
    [TBL] [Abstract][Full Text] [Related]  

  • 30. IL-17A promotes tumorigenesis and upregulates PD-L1 expression in non-small cell lung cancer.
    Liao H; Chang X; Gao L; Ye C; Qiao Y; Xie L; Lin J; Cai S; Dong H
    J Transl Med; 2023 Nov; 21(1):828. PubMed ID: 37978543
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Role of COX-2/PGE2/EP4 Axis-induced Macrophage Functional Activation 
in NSCLC Development].
    Zhao J; Zhu Q; Zhang Y; Li G; Zhang Y; Li F; Bian L
    Zhongguo Fei Ai Za Zhi; 2024 Apr; 27(4):245-256. PubMed ID: 38769827
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Blaps rynchopetera affects proliferation, migration, and invasion of non-small cell lung cancer: a study based on network pharmacology and in vivo and in vitro experiments].
    Li XY; Ma K; Yan JN; You FC; Ma L
    Zhongguo Zhong Yao Za Zhi; 2023 Jul; 48(13):3576-3588. PubMed ID: 37474991
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The role of NFATc1/c-myc/PKM2/IL-10 axis in activating cervical cancer tumor-associated M2 macrophage polarization to promote cervical cancer progression.
    Tan J; Yang L; Zhao H; Ai Y; Ren L; Zhang F; Dong W; Shi R; Sun D; Feng Y
    Exp Cell Res; 2022 Apr; 413(2):113052. PubMed ID: 35122827
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Apatinib triggers autophagic and apoptotic cell death via VEGFR2/STAT3/PD-L1 and ROS/Nrf2/p62 signaling in lung cancer.
    Xie C; Zhou X; Liang C; Li X; Ge M; Chen Y; Yin J; Zhu J; Zhong C
    J Exp Clin Cancer Res; 2021 Aug; 40(1):266. PubMed ID: 34429133
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Macrophage colony stimulating factor enhances non-small cell lung cancer invasion and metastasis by promoting macrophage M2 polarization].
    Li YJ; Yang L; Wang LP; Zhang Y
    Zhonghua Zhong Liu Za Zhi; 2017 Jun; 39(6):412-418. PubMed ID: 28635229
    [No Abstract]   [Full Text] [Related]  

  • 36. Upregulation of PD-L1 by SPP1 mediates macrophage polarization and facilitates immune escape in lung adenocarcinoma.
    Zhang Y; Du W; Chen Z; Xiang C
    Exp Cell Res; 2017 Oct; 359(2):449-457. PubMed ID: 28830685
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Tumor-associated macrophage, angiogenesis and lymphangiogenesis markers predict prognosis of non-small cell lung cancer patients.
    Hwang I; Kim JW; Ylaya K; Chung EJ; Kitano H; Perry C; Hanaoka J; Fukuoka J; Chung JY; Hewitt SM
    J Transl Med; 2020 Nov; 18(1):443. PubMed ID: 33228719
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Antitumor activity of type III interferon alone or in combination with type I interferon against human non-small cell lung cancer.
    Fujie H; Tanaka T; Tagawa M; Kaijun N; Watanabe M; Suzuki T; Nakayama K; Numasaki M
    Cancer Sci; 2011 Nov; 102(11):1977-90. PubMed ID: 21883692
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Effects of gene silencing of indoleamine 2,3-dioxygenase 1 combined with rosmarinic acid on tumor immune microenvironment in H22 tumor-bearing mice.
    Cao W; Pan J; Mo K; Wang Z; Wei S; Yin Y; Qin M; Zhang W
    Int Immunopharmacol; 2023 Jun; 119():110193. PubMed ID: 37062258
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Total glucosides of paeony inhibit breast cancer growth by inhibiting TAMs infiltration through NF-κB/CCL2 signaling.
    Jin L; Guo Y; Mao W; Wang J; Jin L; Liu X; Shou Q; Fu H
    Phytomedicine; 2022 Sep; 104():154307. PubMed ID: 35841664
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.